 AIkido Pharma Inc. Nasdaq: AIKI today announced it has extended its previously disclosed exclusive option agreement Option with the University of Maryland, Baltimore UMB for the technology set forth in Patent number 10,434,116 Methods of Treating Coronavirus Infection. The present invention provides methods for treating a coronavirus infection. The initial Option for Treatment of Coronavirus was previously disclosed on March 6, 2020. The Option has been extended until December 2, 2020. All other terms and conditions of the original Option agreement remain in full force and effect. 